Veleka Peeples-Dyer - Jun 1, 2023 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role
Director
Signature
/s/ Shawn Glidden, attorney-in-fact
Stock symbol
REPL
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 08:13 AM
Next filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REPL Employee Stock Option (right to buy) Award $0 +50.4K $0.00 50.4K Jun 1, 2023 Common Stock 50.4K $18.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this stock option vest on June 1, 2024, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter.